Coronavirus SARS-CoV-2 infection: high risk conditions

High-risk disorders

• Active immune neurological disorder
• Respiratory muscle weakness with < 60% predicted FVC
• Cardiomyopathy
• Cardiac drugs: ACE inhibitors or beta blockers
• Uncontrolled neuromuscular junction (NMJ) disorders
• Motor neuron disease (MND) requiring non-invasive ventilatory support

High risk medical co-morbidities

High risk medications

Synonym

References

1. Association of British Neurologists Guidance on COVID-19 for people with neurological conditions, their doctors and carers. ABN 2020. Accessed 03.04.2020.

Related checklists

• Coronavirus SARS-CoV-2 infection: epidemiology and prognosis
• Coronavirus SARS-CoV-2 infection: systemic features
• Coronavirus SARS-CoV-2 infection: central vascular features
• Coronavirus SARS-CoV-2 infection: central non-vascular features
• Coronavirus SARS-CoV-2 infection: cranial nerve disorders
• Coronavirus SARS-CoV-2 infection: peripheral features
• Coronavirus SARS-CoV-2 infection: neurological investigations
• Coronavirus SARS-CoV-2 infection: systemic investigations
• Coronavirus SARS-CoV-2 infection: treatments
• Coronavirus SARS-CoV-2 infection: neurological disorders recommendations
• Coronavirus SARS-CoV-2 infection: multiple sclerosis (MS) recommendations
• Coronavirus SARS-CoV-2 vaccine: cerebral vein thrombosis (CVT)
• Coronavirus SARS-CoV-2 vaccine: other neurological complications
• Coronavirus SARS-CoV-2 vaccine systemic complications
• Coronavirus SARS-CoV-2 infection: long COVID